Form 4: Repligen CEO Olivier Loeillot Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Repligen's CEO, Olivier Loeillot, disposed of 861 shares of common stock to cover tax obligations related to the vesting of restricted stock units.
Summary
- Olivier Loeillot, the CEO of Repligen Corporation, disposed of 861 shares of common stock on November 20, 2024.
- The shares were sold at a price of $123.41 per share.
- This transaction was to cover tax withholding obligations arising from the release of restricted stock units.
- Following the transaction, Mr. Loeillot directly owns 32,556 shares of Repligen stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction for tax purposes, which is neither positive nor negative for the company's performance. The sentiment is neutral to slightly positive as it indicates the executive is receiving stock based compensation.
Industry Context
This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.
Comparison to Industry Standards
- Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
- Similar transactions are regularly reported by executives at companies like Thermo Fisher Scientific, Danaher, and Sartorius, which are also in the life sciences and biotechnology sector.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
- The sale does not indicate any change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 09/20/2024 | Date of execution of the Power of Attorney. |
| 11/20/2024 | Date of the stock transaction. |
| 11/21/2024 | Date of filing of the Form 4. |
Keywords
Repligen, Olivier Loeillot, stock sale, Form 4, insider trading, tax obligations, restricted stock units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.